India vs South-East Asia (WHO region): New or unknown treatment history cases: Pulmonary, bacteriologically
India
1.01 million
in 2023
South-East Asia (WHO region)
1.69 million
in 2023
India rank
1st
South-East Asia (WHO region) rank
3rd
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- India
- South-East Asia (WHO region)
How they compare
South-East Asia (WHO region) currently reports 1.69 million against 1.01 million in India, a difference of 676,360.
That makes South-East Asia (WHO region)'s figure about 1.7 times India's.
Across all 11 years both countries report, South-East Asia (WHO region) has been ahead every year.
India ranks 1st and South-East Asia (WHO region) ranks 3rd of 197 countries.
South-East Asia (WHO region) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | India | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 783,287 | 1.25 million | 469,992 | South-East Asia (WHO region) |
| 2020s | 866,264 | 1.43 million | 562,321 | South-East Asia (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, India or South-East Asia (WHO region)?
- South-East Asia (WHO region), at 1.69 million against 1.01 million in India as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between India and South-East Asia (WHO region)?
- 676,360, with South-East Asia (WHO region) ahead.
- How many years of comparable data are there for India and South-East Asia (WHO region)?
- 11 years are reported by both, from 2013 to 2023.
- How do India and South-East Asia (WHO region) rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- India ranks 1st and South-East Asia (WHO region) ranks 3rd of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.